Literature DB >> 34413124

World Health Organization treatment outcome definitions for tuberculosis: 2021 update.

Nguyen Nhat Linh1, Kerri Viney2, Medea Gegia2, Dennis Falzon2, Philippe Glaziou2, Katherine Floyd2, Hazim Timimi2, Nazir Ismail2, Matteo Zignol2, Tereza Kasaeva2, Fuad Mirzayev2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34413124     DOI： 10.1183/13993003.00804-2021

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   33.795


× No keyword cloud information.
  4 in total

1.  Study on the Correlation between Interleukin-27 and CXCL10 in Pulmonary Tuberculosis.

Authors:  Jiahui Fan; Yefeng Yang; Liang Wang; Xiaoqian Shang; Li Zhang; Hu Sun; Yujie Ma; Ying Li; Jing Wang; Xiumin Ma
Journal:  J Immunol Res       Date:  2022-06-22       Impact factor: 4.493

2.  Comparison of different regimens with or without fluoroquinolone in isoniazid-resistant tuberculosis: A multicenter cohort study.

Authors:  Jinsoo Min; Hyung Woo Kim; Ji Young Kang; Sung Kyoung Kim; Jin Woo Kim; Yong Hyun Kim; Hyoung Kyu Yoon; Sang Haak Lee; Ju Sang Kim
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

3.  Treatment With a Three-Drug Regimen for Pulmonary Tuberculosis Based on Rapid Molecular Detection of Isoniazid Resistance: A Noninferiority Randomized Trial (FAST-TB).

Authors:  N De Castro; F Mechaï; D Bachelet; A Canestri; V Joly; M Vandenhende; D Boutoille; M Kerjouan; N Veziris; J M Molina; N Grall; P Tattevin; C Laouénan; Y Yazdanpanah
Journal:  Open Forum Infect Dis       Date:  2022-07-25       Impact factor: 4.423

4.  The Emergence of Novel Spoligotypes of Highly Drug-Resistant Mycobacterium tuberculosis Isolates in Fujian, China.

Authors:  Shufang Lin; Shuzhen Wei; Yong Zhao; Zhisong Dai; Jian Lin; Yu Pang
Journal:  Infect Drug Resist       Date:  2022-10-01       Impact factor: 4.177
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.